Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age. : HP5-139/1-2022E-PDF ; HP5-139/2-2022E-PDF
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.913119&sl=1
Ministère/Organisme | Public Health Agency of Canada, issuing body. |
---|---|
Titre | Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age. |
Type de publication | Monographie |
Langue | [Anglais] |
Autres langues publiées | [Français] |
Format | Électronique |
Document électronique |
|
Note(s) | Issued also in French under title: Recommandations sur l'utilisation du vaccin Spikevax de Moderna contre la COVID-19 chez les enfants de 6 mois à 5 ans. At head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). Issued also in HTML format. Includes bibliographical references (pages 25-27). |
Information sur la publication | Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, July 14, 2022. ©2022 |
Description | 1 online resource (27 pages) + summary (6 pages) |
ISBN | 9780660444543 9780660444550 |
Numéro de catalogue |
|
Numéro de catalogue du ministère | 220315 (main report) 220313 (summary) |
Descripteurs | COVID-19 (Disease) -- Vaccination -- Canada. Vaccination of children -- Canada. |